Cover Image
市場調查報告書

血栓管理設備的全球市場:2015年∼2019年

Global Clot Management Devices Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 328863
出版日期 內容資訊 英文 75 Pages
訂單完成後即時交付
價格
Back to Top
血栓管理設備的全球市場:2015年∼2019年 Global Clot Management Devices Market 2015-2019
出版日期: 2015年04月22日 內容資訊: 英文 75 Pages
簡介

全球血栓管理設備市場預測在2014年∼2019年這段期間將以年複合成長率5.95%的速度成長。

本報告提供全球血栓管理設備市場場相關調查分析,提供您市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 提供產品

第4章 市場調查手法

  • 市場概要流程
  • 調查手法

第5章 簡介

  • 血栓相關的風險要素
  • VTE (靜脈血栓栓塞症) 的流行病學
  • VTE的病理學
  • 血栓:各類型

第6章 市場形勢

  • 市場概要
  • 市場規模·預測
  • 波特的五力分析

第7章 市場區隔:不同設備

第8章 地區區分

第9章 南北美洲

  • 市場規模·預測

第10章 EMEA (歐洲·中東·非洲)

  • 歐洲主要整形外科手術後VTE的經濟負擔
  • 市場規模·預測

第11章 APAC (亞太地區)

  • 市場規模·預測

第12章 購買標準

第13章 推動市場成長要素

第14章 推動因素與其影響

第15章 市場課題

第16章 推動因素與課題的影響

第17章 市場趨勢

第18章 趨勢與其影響

第19章 業者情勢

  • 競爭情形
  • 市場佔有率分析
  • 其他有潛力的供應商

第20章 主要供應商分析

  • AngioDynamics
  • Boston Scientific
  • Cook Medical
  • Stryker

第21章 相關報告

圖表清單

目錄
Product Code: IRTNTR5749

About clot management devices

A blood clot or thrombus is the end stage of blood coagulation process in hemostasis. Blood clot is the body's response to an injury to prevent bleeding. However, a clot can be harmful when it forms abnormally to obstruct blood flow through healthy blood vessels. This condition is called thrombosis. A blood clot in arteries can lead to heart attack, while blood clot formed in the deep veins can lead to DVT or PE. Clot management devices help in the removal of a clot or dissolving clot in the blood vessels.

Technavio's analysts forecast the global clot management devices market to grow at a CAGR of 5.95 percent over the period 2014-2019.

Covered in this report

The report covers the present scenario and the growth prospects of the global clot management devices market for the period 2015-2019. Based on type of devices, the market can be segmented as follows: percutaneous thrombectomy devices, embolectomy balloon catheters, catheter-directed thrombolysis, IVCF, and neurovascular embolectomy devices.

Technavio's report, the Global Clot Management Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA; it also covers the global clot management devices market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • AngioDynamics
  • Boston Scientific
  • Cook Group
  • Stryker

Other Prominent Vendors

  • Acandis
  • Argon Medical Devices
  • Asid Bonz
  • Biosensors International Group
  • Control Medical Technology
  • Covidien
  • DePuy Synthes
  • Dispomedica
  • Edwards Lifesciences
  • EKOS (a BTG International Group company)
  • Eurocor
  • FBMedical-ISOMed
  • iVascular
  • LeMaitre Vascular
  • Merit Medical
  • Phenox
  • Straub Medical
  • Teleflex

Market driver

  • Growing awareness of endovascular treatment
  • For a full, detailed list, view our report

Market challenge

  • Acceptance of anticoagulant therapy
  • For a full, detailed list, view our report

Market trend

  • Increase in number of MIS procedures
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market overview
  • 03.2. Product offerings

04. Market Research Methodology

  • 04.1. Market research process
  • 04.2. Research methodology

05. Introduction

  • 05.1. Risk factors associated with blood clots
  • 05.2. Epidemiology of VTE
  • 05.3. Pathophysiology of VTE
  • 05.4. Blood clot by type

06. Market Landscape

  • 06.1. Market overview
  • 06.2. Market size and forecast
  • 06.3. Five forces analysis

07. Market Segmentation by Device

08. Geographical Segmentation

09. Americas

  • 09.1. Market size and forecast

10. EMEA

  • 10.1. Economic burden of VTE following major orthopedic surgery in Europe
  • 10.2. Market size and forecast

11. APAC

  • 11.1. Market size and forecast

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

  • 19.1. Competitive scenario
    • 19.1.1. Key news
    • 19.1.2. Mergers and acquisitions
  • 19.2. Market share analysis 2013
  • 19.3. Other prominent vendors

20. Key Vendor Analysis

  • 20.1. AngioDynamics
    • 20.1.1. Key facts
    • 20.1.2. Business overview
    • 20.1.3. Business segmentation
    • 20.1.4. Business strategy
    • 20.1.5. Revenue segmentation by category of product
    • 20.1.6. Revenue segmentation by geography
    • 20.1.7. Key information
    • 20.1.8. SWOT analysis
  • 20.2. Boston Scientific
    • 20.2.1. Key facts
    • 20.2.2. Business Overview
    • 20.2.3. Business segmentation
    • 20.2.4. Business segmentation by revenue 2013
    • 20.2.5. Business segmentation by revenue 2012 and 2013
    • 20.2.6. Geographical segmentation by revenue 2013
    • 20.2.7. Business strategy
    • 20.2.8. Key developments
    • 20.2.9. SWOT analysis
  • 20.3. Cook Medical
    • 20.3.1. Key facts
    • 20.3.2. Business overview
    • 20.3.3. Key divisions
    • 20.3.4. Geographical segmentation 2013
    • 20.3.5. Business strategy
    • 20.3.6. Recent developments
    • 20.3.7. SWOT analysis
  • 20.4. Stryker
    • 20.4.1. Key facts
    • 20.4.2. Business overview
    • 20.4.3. Business segmentation by revenue 2013
    • 20.4.4. Business segmentation by revenue 2012 and 2013
    • 20.4.5. Geographical segmentation by revenue 2013
    • 20.4.6. Business strategy
    • 20.4.7. Recent developments
    • 20.4.8. SWOT analysis

21.Other Reports in this Series

List of Exhibts:

  • Exhibit 1: Market research methodology
  • Exhibit 2: Risk factors associated with blood clots
  • Exhibit 3: VTE incidences in US
  • Exhibit 4: Other incidences
  • Exhibit 5: Types of blood clot
  • Exhibit 6: Risk factors for DVT
  • Exhibit 7: Risk factors for PE
  • Exhibit 8: Global clot management devices market 2014-2019 ($ million)
  • Exhibit 9: Segmentation by device
  • Exhibit 10: Segmentation of global clot management devices market by geography 2014
  • Exhibit 11: Clot management devices market 2014-2019 ($ million)
  • Exhibit 12: VTE disease burden in Europe
  • Exhibit 13: Total number of VTE events per year within six European countries
  • Exhibit 14: Relative distribution of diagnosed and undiagnosed PE among fatal VTE events
  • Exhibit 15: Clot management devices market 2014-2019 ($ million)
  • Exhibit 16: Clot management devices market 2014-2019 ($ million)
  • Exhibit 17: Segmentation of global clot management devices market by geography 2014-2019
  • Exhibit 18: Segmentation of global clot management devices market by geography 2014-2019 ($ million)
  • Exhibit 19: Segmentation of global clot management devices market by geography 2014 and 2019
  • Exhibit 20: Segmentation of global clot management devices market by geography 2014 and 2019 ($ million)
  • Exhibit 21: Endovascular treatment of stroke
  • Exhibit 22: Clinical evidence
  • Exhibit 23: AngioDynamics: business segmentation by category of product
  • Exhibit 24: AngioDynamics: segmentation of revenue by category of product 2014
  • Exhibit 25: AngioDynamics: segmentation of revenue by geography 2014
  • Exhibit 26: Boston Scientific: business segmentation 2013
  • Exhibit 27: Boston Scientific: business segmentation by revenue 2013
  • Exhibit 28: Boston Scientific: business segmentation by revenue 2012 and 2013 ($ million)
  • Exhibit 29: Boston Scientific: geographical segmentation by revenue 2013
  • Exhibit 30: Cook Medical: key divisions
  • Exhibit 31: Cook Medical: geographical segmentation 2013
  • Exhibit 32: Stryker: business segmentation by revenue 2013
  • Exhibit 33: Stryker: business segmentation by revenue 2012 and 2013 ($ million)
  • Exhibit 34: Stryker: geographical segmentation by revenue 2013
Back to Top